1,883
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Application of an immunoglobulin Y-alkaline phosphatase bioconjugate as a diagnostic tool for influenza A virus

, , , &
Pages 33-42 | Received 19 Feb 2018, Accepted 15 Feb 2019, Published online: 27 Mar 2019

References

  • Poon LL, Leung CS, Chan KH, et al. Detection of human influenza A viruses by loop-mediated isothermal amplification. J Clin Microbiol. 2005;43:427–430.
  • De Filette M, Martens W, Roose K, et al. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J Biol Chem. 2008;283:11382–11387.
  • Grubu KVTSÇ. İnfluenza ve Avian İnfluenzanın Mikrobiyolojik Tanısı. In: Bakanlığı TCS, editor. Ulusal Mikrobiyoloji Standartları. Ankara:  T.C. Sağlık Bakanlığı Yayınları; 2015. p. 2–17.
  • Rosas-Murrieta N, Herrera-Camacho I, Millán-Pérez-Peña L, et al. Molecular diagnostics as an indispensable tool for the diagnosis of infectious diseases of viral origin and global impact. In: Shailendra KS, editor. Trends in infectious diseases. India: InTech; 2014.
  • Amano Y, Cheng Q. Detection of influenza virus: traditional approaches and development of biosensors. Anal Bioanal Chem. 2005;381:156–164.
  • Bucher D, Mikhail A, Popple S, et al. Rapid detection of type A influenza viruses with monoclonal antibodies to the M protein (M1) by enzyme-linked immunosorbent assay and time-resolved fluoroimmunoassay. J Clin Microbiol. 1991;29:2484–2488.
  • Kamps BS, Hoffmann C, Preiser W. Influenza report 2006. Germany: Flying Publisher;2006.
  • Zhao G, Lin Y, Du L, et al. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol J. 2010;7:9.
  • Yong CY, Yeap SK, Ho KL, et al. Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles. Int J Nanomedicine. 2015;10:2751.
  • Zhong W, He J, Tang X, et al. Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses. J Immunol Methods. 2011;369:115–124.
  • Hemmatzadeh F, Sumarningsih S, Tarigan S, et al. Recombinant M2e protein-based ELISA: A novel and inexpensive approach for differentiating avian influenza infected chickens from vaccinated ones. PloS one. 2013;8:e56801.
  • De Filette M, Jou WM, Birkett A, et al. Universal influenza A vaccine: optimization of M2-based constructs. Virology. 2005;337:149–161.
  • Zebedee SL, Lamb RA. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol. 1988;62:2762–2772.
  • Pejoski D, Zeng W, Rockman S, et al. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. Immunol Cell Biol. 2010;88:605–611.
  • Lee Y-N, Kim M-C, Lee Y-T, et al. Mechanisms of cross-protection by influenza virus M2-based vaccines. Immune Netw. 2015;15:213–221.
  • Zeng W, Tan ACL, Horrocks K, et al. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate. Vaccine. 2015;33:3526–3532.
  • Muto NA, Yoshida R, Suzuki T, et al. Inhibitory effects of an M2-specific monoclonal antibody on different strains of influenza A virus. Jpn J Vet Res. 2012;60:71–83.
  • Mardanova ES, Kotlyarov RY, Kuprianov VV, et al. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors. BMC Biotechnol. 2015;15:42.
  • Saelens X. The influenza matrix protein 2 as a vaccine target. Future Medicine 2008;3: 167-178.
  • Boivin G, Hardy I, Kress A. Evaluation of a rapid optical immunoassay for influenza viruses (FLU OIA test) in comparison with cell culture and reverse transcription-PCR. J Clin Microbiol. 2001;39:730–732.
  • Shojaei TR, Tabatabaei M, Shawky S, et al. A review on emerging diagnostic assay for viral detection: the case of avian influenza virus. Mol Biol Rep. 2015;42:187–199.
  • Soema PC, Kompier R, Amorij J-P, et al. Current and next generation influenza vaccines: formulation and production strategies. Eur J Pharm Biopharm. 2015;94:251–263.
  • Kumar S, Henrickson KJ. Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev. 2012;25:344–361.
  • Coughlan L, Lambe T. Measuring cellular immunity to influenza: methods of detection, applications and challenges. Vaccines (Basel). 2015;3:293–319.
  • Stanker LH, Hnasko RM. A double-sandwich ELISA for identification of monoclonal antibodies suitable for sandwich immunoassays. ELISA. New York: Springer; 2015. p. 69–78.
  • Li X, Wang L, Zhen Y, et al. Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review. J Anim Sci Biotechnol. 2015;6:40.
  • Hatta H, Kim M, Yamamoto T. A novel isolation method for hen egg yolk antibody,“IgY”. Agric Biol Chem. 1990;54:2531–2535.
  • Tong C, Geng F, He Z, et al. A simple method for isolating chicken egg yolk immunoglobulin using effective delipidation solution and ammonium sulfate. Poult Sci. 2014;94:104–110.
  • Justiz Vaillant A, Ramirez N, Cadiz A, et al. Separation and reactivity of avian immunoglobulin Y. J Chromatogr Sep Tech. 2013;4:173.
  • Suzuki U, Yoshimura K, Takaishi M. Ueber ein Enzym “Phytase” das “Anhydro-oxy-methylen diphosphorsaure” Spaltet. Tokyo Imper Univ Coll Agric Bull. 1907;7:503–512.
  • Rankin S, Christiansen A, Lee W, et al. Invited review: the application of alkaline phosphatase assays for the validation of milk product pasteurization. J Dairy Sci. 2010;93:5538–5551.
  • Gibbs J, Kennebunk M. Selecting the detection system—colorimetric, fluorescent, luminescent methods. Corning Life Sci ELISA Tech Bull. 2001;5;14.
  • Lü H. FTIR analysis of the impact of covalent coupling on the secondary structure of antibody protein. Spectrosc Spectral Anal. 2012;32:630–634.
  • de La Fournière L, Nosjean O, Buchet R, et al. Thermal and pH stabilities of alkaline phosphatase from bovine intestinal mucosa: a FTIR study. Biochim Biophys Acta (BBA)-Protein Struct Mol Enzymol. 1995;1248:186–192.
  • Kilinç Y, Cakır-Koc R, Badur S. The development of a universally conserved m2e and hemagglutinin peptide-based elisa method against influenza a. J Clin Anal Med. 2017;8:320–323.
  • Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G. Immunochemistry. 1971;8:871–874.
  • Ingrole RS, Tao W, Tripathy JN, et al. Synthesis and immunogenicity assessment of elastin-like polypeptide-M2e construct as an influenza antigen. Nano Life. 2014;4:1450004.
  • Khurana S, Sasono P, Fox A, et al. H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance. J Virol. 2011;85:12455–12463.
  • Budama‐Kilinc Y, Cakir‐Koc R. Influenza diagnosis with a specific emphasis on the M2e antigen as a diagnostic tool. In: Manal MB, editor. Steps forwards in diagnosing and controlling influenza. Rijeka: InTech; 2016.
  • Polson A, Caton J, Yeaple R, et al. Histological determination of probe tip penetration into gingival sulcus of humans using an electronic pressure‐sensitive probe. J Clin Periodontol. 1980;7:479–488.
  • Pauly D, Chacana PA, Calzado EG, et al. IgY technology: extraction of chicken antibodies from egg yolk by polyethylene glycol (PEG) precipitation. J vis exp. 2011.
  • Walczak M, Grzywa R, Łupicka‐Słowik A, et al. Method for generation of peptide‐specific igy antibodies directed to Staphylococcus aureus extracellular fibrinogen binding protein epitope. Pept Sci. 2015;104:552–559.
  • Áf J, Santiago FM, Silva MV, et al. Production, characterization and applications for Toxoplasma gondii-specific polyclonal chicken egg yolk immunoglobulins. PLoS One. 2012;7:e40391.
  • WHO. CDC protocol of realtime RTPCR for influenza A(H1N1). USA: WHO; 2009.
  • WHO. WHO information for molecular diagnosis of influenza virus – update. China: WHO; 2018.
  • He Q, Velumani S, Du Q, et al. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin Vaccin Immunol. 2007;14:617–623.